Sitaram Ghogale

Tata Memorial Hospital — India

Medicine · Health Sciences

13h-index538citations62works1.62yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Lymphoblastic Leukemia research(22), Acute Myeloid Leukemia Research(16), Multiple Myeloma Research and Treatments(16), Lymphoma Diagnosis and Treatment(15), Chronic Lymphocytic Leukemia Research(13)

Publications62 total

Hemodilution assessment for high-sensitivity flow cytometric measurable residual disease evaluation in pediatric B-cell acute lymphoblastic leukemia
Blood·2025Open Access
Detectable Peripheral Blood Measurable Residual Disease (PBMRD) is Strongly Associated with Early Progression in Newly Diagnosed Multiple Myeloma (NDMM)
Clinical Lymphoma Myeloma & Leukemia·2025
404 | CLINICAL RELEVANCE OF PERIPHERAL BLOOD MEASURABLE RESIDUAL DISEASE ASSESSMENT IN NEWLY DIAGNOSED MULTIPLE MYELOMA AFTER INITIAL THERAPY: A PROSPECTIVE STUDY
Hematological Oncology·2025Open Access
Leukemic Stem Cell Measurable Residual Disease (LSC MRD) Status Is a Better Predictor of Relapse Than Multiparametric Flowcytometric Analysis in Acute Myeloid Leukemia Patients
Blood·2024· 1 cited
Myelodysplasia-Related Mutations in Adults and End-of-Induction Measurable Residual Disease Are Associated with Inferior Outcome in Patients with Acute Leukemia of Ambiguous Lineage
Blood·2024Open Access
Quantitation of Leukemic Stem Cell-like Cells (LSC) Burden at Diagnosis Identifies Clinical Heterogeneity in the ELN22 Risk Stratification of Acute Myeloid Leukemia (AML)
Blood·2024
Utility of leukocyte‐associated immunoglobulin‐like receptor‐1 (<scp>CD305</scp>) in flow cytometric detection of minimal bone marrow involvement by <scp>B</scp>‐cell non‐<scp>Hodgkin</scp> lymphoma
Cytometry Part B Clinical Cytometry·2024· 3 citedOpen Access
Circulating tumor plasma cells and peripheral blood measurable residual disease assessment in multiple myeloma patients not planned for upfront transplant
HemaSphere·2024· 9 citedOpen Access
15‐color highly sensitive flow cytometry assay for post <scp>anti‐CD19</scp> targeted therapy (<scp>anti‐CD19‐CAR‐T</scp> and blinatumomab) measurable residual disease assessment in B‐lymphoblastic leukemia/lymphoma: Real‐world applicability and challenges
European Journal Of Haematology·2023· 9 citedOpen Access
Long-Term Cryopreservation of Peripheral Blood Stem Cell Harvest Using Low Concentration (4.35%) Dimethyl Sulfoxide with Methyl Cellulose and Uncontrolled Rate Freezing at -80 °C: An Effective Option in Resource-Limited Settings
Transplantation and Cellular Therapy·2023· 8 cited
P360: MEASURABLE/MINIMAL RESIDUAL DISEASE (MRD) STATUS IS THE MOST RELEVANT INDICATOR OF CLINICAL OUTCOME IN MIXED PHENOTYPIC ACUTE LEUKEMIAS (MPAL)
HemaSphere·2023Open Access
PB1949: ROLE OF LAIR1 (CD305) IN FLOW CYTOMETRIC DETECTION OF OCCULT BONE MARROW INVOLVEMENT IN NON-CLL B-CELL NON-HODGKIN LYMPHOMA
HemaSphere·2023· 1 citedOpen Access
Serum microRNA Signature Predicting Poor Therapeutic Response to Bortezomib-Based Therapy and Clinical Outcome in Newly Diagnosed Multiple Myeloma: A Result of miRNA Profiling By Deep Sequencing
Blood·2022
Circulating Clonal Plasma Cells at Diagnosis and Peripheral Blood Measurable Residual Disease Assessment Provide Powerful Prognostication Biomarkers in Newly-Diagnosed Multiple Myeloma Patients Treated without Autologous Transplant
Blood·2022· 2 cited
Expression levels and patterns of B‐cell maturation antigen in newly diagnosed and relapsed multiple myeloma patients from Indian subcontinent
Cytometry Part B Clinical Cytometry·2022· 8 cited
Utility of Flow Cytometry in Cytokine Profiling from Human Plasma Samples
Indian Journal of Medical and Paediatric Oncology·2022Open Access
Study of FGFR-3 by Flow Cytometry is Highly Sensitive and Specific For Prediction of t(4;14) Translocation In Multiple Myeloma.
Indian Journal of Medical and Paediatric Oncology·2022Open Access
Clinical Utility Cytoplasmic TRBC1 Expression in the Diagnosis and Minimal Residual
Indian Journal of Medical and Paediatric Oncology·2022· 2 citedOpen Access
Expression Pattern of a New Marker, Gl7 in Different Stages of B-Cell Maturation and Its Utility in B-Lymphoblastic Leukemia/Lymphoma Measurable Residual Disease Assessment
Indian Journal of Medical and Paediatric Oncology·2022Open Access
Role of GATA3-Expression in the T-Cell Lineage Assignment for the Diagnosis and Classification of Acute Leukemia
Indian Journal of Medical and Paediatric Oncology·2022Open Access
page 1 of 4Next →

Frequent Co-authors

Prashant Tembhare(45), Papagudi Ganesan Subramanian(44), Sumeet Gujral(44), Nikhil Patkar(43), Nilesh Deshpande(40), Gaurav Chatterjee(36), Yajamanam Badrinath(30), Sweta Rajpal(21), Karishma Girase(20), Twinkle Khanka(20), Harshini Sriram(18), Navin Khattry(16), Bhausaheb Bagal(14), Manju Sengar(14), Hasmukh Jain(13), Gaurav Narula(12), Anant Gokarn(10), Shripad Banavali(8), Sachin Punatar(8), Dhanalaxmi Shetty(7)